Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million [Yahoo! Finance]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance
Casdin Capital reduced its stake in Structure Therapeutics (NASDAQ:GPCR) by 380,000 shares in the fourth quarter, an estimated $15.52 million trade based on quarterly average pricing, per a February 17, 2026, SEC filing. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Casdin Capital sold 380,000 shares of Structure Therapeutics during the fourth quarter. The estimated value of this trade is $15.52 million based on the period's average share price. The quarter-end position value shifted by $38.18 million, a figure that incorporates both trading activity and changes in market value. What else to know This was a reduction in holdings; Structure Therapeutics accounted for 5.08% of Casdin's 13F assets after the sale. Top five holdings after the filing: NASDAQ:WGS: $391.11 million (24.3% of AUM) NASDAQ:RVMD: $205.28 million (12.8% of AUM) NASDAQ:BLFS: $144.04 million (8.9% of AUM) NASDAQ:LAB: $113.64 million (7.1% of A
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Assessing Structure Therapeutics (GPCR) Valuation After Sharp Swings And A Strong 1 Year Return [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (GPCR) had its price target lowered by Citizens Jmp from $120.00 to $113.00. They now have a "market outperform" rating on the stock.MarketBeat
- Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent HighlightsGlobeNewswire
- Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position [Yahoo! Finance]Yahoo! Finance
GPCR
Sec Filings
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- GPCR's page on the SEC website